Traws Pharma, Inc.
TRAW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001130598
No open-market purchases or sales by Traws Pharma, Inc. insiders were filed in the last 90 days; 34 institutions reported holding it in 13F filings for Q2 2026, worth $5.19M in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding Traws Pharma, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 27 | 26 | −1 |
| Shares | 1.82M | 1.86M | +45.5K (+2.5%) |
| Value | $1.35M | $1.88M | +$526.9K (+38.9%) |
New holders (4)
Institutions that held Traws Pharma, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 36,819 | $37.2K | 0.00% |
| FMR LLC | 1,000 | $1.01K | 0.00% |
| Old Point Trust & Financial Services N A | 166 | $168 | 0.00% |
| Cornerstone Planning Group LLC | 33 | $21 | 0.00% |
Sold out (5)
Institutions that held Traws Pharma, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Hillcrest Wealth Advisors - NY, LLC | 16,723 | $12.5K |
| Millennium Management LLC | 15,489 | $11.5K |
| Bank of America Corp | 679 | $506 |
| TD Waterhouse Canada Inc. | 120 | $87 |
| Simplex Trading, LLC | 107 | $0 |